Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Syusuke Okamura"'
Autor:
Marianna Silletta, V. Burgio, Gianluca Masi, A. Takata, M.G. Viola, Mario Domenico Rizzato, Kazuto Tajiri, H. Toyoda, M. Scartozzi, Francesca Salani, Syusuke Okamura, Francesco Giuseppe Foschi, Takashi Kumada, G. Astara, I.G. Rapposelli, Fabio Conti, Emiliano Tamburini, Claudia Campani, Kazuhito Kawata, Fabio Marra, A. Forgione, A. Hiraoka, Giovanni Luca Frassineti, R. Tortora, Takuji Torimura, Shigeo Shimose, Masahito Nakano, Masanori Atsukawa, Stefano Cascinu, Andrea Casadei-Gardini, H. Shibata, G.G. Di Costanzo, Caterina Vivaldi, Antonio Pellino, Claudia Angela Maria Fulgenzi, Toshifumi Tada, Eleonora Lai, Fabio Piscaglia, S. Lonardi, Margherita Rimini
Publikováno v:
ESMO Open
Background After the advent of new treatment options for advanced hepatocellular carcinoma (HCC), the identification of prognostic factors is crucial for the selection of the most appropriate therapy for each patient. Patients and methods With the ai
Autor:
Masatoshi Tanaka, Toshi Abe, Naoki Kamachi, Mika Nomiyama, Ryoko Kuromatsu, Masahito Nakano, Takashi Niizeki, Hiroyuki Suzuki, Hideki Iwamoto, Takuji Torimura, Etsuyo Ogo, Manabu Satani, Syusuke Okamura, Hironori Koga, Shigeo Shimose, Miwa Sakai, Yu Noda, Tomotake Shirono
Publikováno v:
Oncology. 96:192-199
Aim: Prognosis of hepatocellular carcinoma (HCC) with macrovascular invasion (MVI) is extremely poor. However, proper therapeutic strategies have not been established yet. The purpose of this study is to identify the effects of external beam radiatio
Autor:
Ryoko Kuromatsu, Masatoshi Tanaka, Miwa Sakai, Syusuke Okamura, Takuji Torimura, Naoki Kamachi, Tomotake Shirono, Masahito Nakano, Takashi Niizeki, Hiroyuki Suzuki, Yu Noda, Shigeo Shimose, Hironori Koga, Hideki Iwamoto, Mika Nomiyama
Publikováno v:
Oncology. 98(8)
Background and Aims: Conventional transcatheter arterial chemoembolization (C-TACE) and drug-eluting bead (DEB)-based TACE are current treatments for hepatocellular carcinoma (HCC). We compared the therapeutic efficacies and adverse events of these m
Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
Autor:
Takuji Torimura, Yu Noda, Ryoko Kuromatsu, Hideki Iwamoto, Tomotake Shirono, Hironori Koga, Shigeo Shimose, Syusuke Okamura, Naoki Kamachi, Masahito Nakano, Takashi Niizeki
Publikováno v:
ESMO Open
Background The immunological inflammatory biomarkers for advanced hepatocellular carcinoma are unclear. We aimed to investigate the association of immunity and inflammatory status with treatment outcomes in patients with advanced hepatocellular carci